Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 10, 2024
Accession Number:
0001178913-24-003893
Submission Type:
POS AM
CIK:
0001534248
Company Name:
Chemomab Therapeutics Ltd.
File Number:
333-255249